PLUR vs OVID โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OVID Captures Institutional Edge (3โ1 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ovid Therapeutics Inc. Common Stock (OVID) driven by superior Valuation, Momentum & Technical, Options & Structure while PLUR counters with relative strength in Growth & Margin. Fundamentally, PLUR trades at 3.6x Forward P/E with -2454.5% operating margin (-15.8% YoY revenue) versus OVID at 1.8x Forward P/E and -4693.7% operating margin (-88.3% YoY). In options structure, PLUR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OVID sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PLUR Revenue | OVID Revenue | PLUR Op. Margin | OVID Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $0M | N/A | -65800.0% | N/A | PLUR |
| FY2020 | $0M | $10M | -128156.5% | -645.4% | OVID |
| FY2021 | N/A | $210M | N/A | 59.6% | OVID |
| FY2022 | $0M | $0M | -17774.8% | -3696.4% | OVID |
| FY2023 | $0M | $0M | -9493.4% | -15122.7% | PLUR |
| FY2024 | $0M | $0M | -6796.9% | -10933.7% | PLUR |
| FY2025 | $0M | $10M | -1659.9% | -585.2% | OVID |
| FY2026 | $0M | N/A | -2454.5% | N/A | PLUR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PLUR | OVID | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $15.1M | $479.4M | Larger Scale | OVID |
| Trailing P/E Ratio Valuation | 3.6x | 1.8x | Lower Multiple | OVID |
| Forward P/E Ratio Valuation | 3.6x | 1.8x | Lower Multiple | OVID |
| Revenue Growth (YoY) Growth | -15.8% | -88.3% | Higher Growth | PLUR |
| Operating Margin (TTM) Profitability | -2454.5% | -4693.7% | Higher Margin | PLUR |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1022.0% | -35.4% | Higher ROE | OVID |
| 52-Week Range Position Momentum | 2% ($1โ$5) | 53% ($1โ$3) | Stronger Trend | OVID |
| Beta / 30D Volatility Risk Regime | 0.80ฮฒ ยท 102% Vol | 1.06ฮฒ ยท 99% Vol | Lower Realized Risk | OVID |
| Unified Institutional Score Composite Signal | 28.8 / 100 (SELL) | 52.3 / 100 (HOLD) | Higher Composite | OVID |